MAY 26·SEC EDGARMed
SAYER KEVIN R sold $1.9M of DXCM
SAYER KEVIN R (Executive Chair) sold 26,759 shares of DEXCOM INC (DXCM) at $72.00 ($1.93M total) on 2026-05-21 under a Rule 10b5-1 trading plan.
StockHealthcare · Medical Devices
$DXCM
DEXCOM INC
Price · $DXCMvia TradingView
AI sentiment · 7d5 articles
- Bullish
- 4
- Neutral
- 1
- Bearish
- 0
Top stories · $DXCMMore →
MAY 23·Simply Wall Street
Does DexCom’s (DXCM) Flex Launch in Germany Hint at a Broader CGM Access Strategy Shift?
DexCom recently launched Dexcom Flex in Germany, a continuous glucose monitoring (CGM) system for Type 2 diabetes patients not on intensive insulin therapy, indicating a strategic shift to expand market access. This move aims to broaden DexCom's role in diabetes management, targeting a larger demographic and fueling its growth narrative. The article suggests this aligns with DexCom's goal of expanding CGM adoption beyond intensive insulin users, alongside a recent US$1 billion share repurchase program.
MAY 23·Simply Wall Street
Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables
Abbott Laboratories is expanding its focus on digital health by introducing new cardiovascular diagnostics and wearable devices like its Lingo biomarker. This strategic shift aims to deepen customer relationships and drive long-term revenue growth, despite potential near-term pressures on margins from increased R&D and software investments. Investors are encouraged to monitor the adoption rates of these new technologies and how Abbott balances its digital health spending with existing product lines.